Having trouble accessing articles? Reset your cache.

PMX-60056: Phase Ib/II data

In an open label, dose-ranging Phase Ib/II trial in 12 healthy volunteers, PMX-60056 reversed the anticoagulant activity of

Read the full 181 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE